Roche Financials

Market Capitalization CHF198.66 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	18.67
Forward PE	12.07
Price to Sales TTM	CHF3.28
Price to Book MRQ	CHF6.81
Enterprise to Revenue	3.76
Enterprise to EBITDA	10.83

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	17.53%
Operating Margin	35.27%
Return on Assets TTM	12.49%
Return on Equity TTM	36.36%

Income Statement

Revenue TTM	CHF60,580,999,168
Revenue per Share TTM	CHF75.92
Quarterly Revenue Growth	0.50%
Gross Profit TTM	CHF44,084,000,000
EBITDA	CHF18,657,000,000
Net Income to Common TTM	CHF10,618,999,808
Diluted EPS TTM	CHF13.25
Quarterly Earnings Growth YoY	-12.30%

Balance Sheet

Total Cash MRQ	CHF8,814,000,128
Total Cash per Share MRQ	CHF11.06
Total Debt MRQ	CHF
Total Debt to Equity MRQ	110.04
Current Ratio MRQ	1.26
Book Value per Share MRQ	CHF36.32

Cash Flow

Operating Cash Flow TTM	CHF16,110,999,552
Levered Free Cash Flow TTM	CHF8,125,374,976

ROG Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	690,097,984
Float Shares	727,014,305
Avg 10 Volume	1,153,815
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.00%
% Held by Institutions	38.37%

Stock Price Summary

Beta	0.15
Fifty Two Week Low	CHF212.90
Fifty Two Week High	CHF288.20
Fifty Two Week Change	10.24%
Day 50 MA	CHF262.25
Day 200 MA	CHF253.50

Dividends and Splits

Forward Annual Dividend Rate	CHF38.40
Forward Annual Dividend Yield	13.97%
Trailing Annual Dividend Rate	CHF9.60
Trailing Annual Dividend Yield	3.49%
Payout Ratio	72.51%
Dividend Date	2024-03-18
Ex Dividend Date	2024-03-14
Last Split Factor
Last Split Date	2001-05-04